Anesthesia for Vascular Surgery Flashcards
Major Co-existing diseases of PVD
Coronary artery disease
May require preoperative coronary revascularization
COPD
Hypertension
Renal insufficiency
Uncontrolled Diabetes
Liver disease
____________ remains the single most important cause of morbidity following vascular surgery
Myocardial dysfunction
Goals of Vascular Anesthesia
Minimize patient morbidity and maximize surgical benefit
Considerations: CNS – Renal – Liver – Gut
Predictors of M&M after vascular surgery
Low serum albumin levels
ASA status (comorbid conditions)
Perioperative Monitoring Goals
for vascular surgery patients
Detect myocardial ischemia
Identify abnormalities
Preload -afterload -ventricular function
Pharmacologic Interventions for Vascular Surgery
** beta-blockers** (metoprolol -atenolol –esmolol)
alpha-2 agonists (pretreatment with clonidine 300 mcg 90min before surgery)
Calcium channel blockers (diltiazem – Clevidipine)
**Nitroglycerin **(used to treat arterial hypertension, elevated cardiac filling pressures and vasospasm)
Patho of the chornic inflammation in vascular disease
Adhesion molecules
Leukocytes: Lipid accretion & vasculitis
Markers of inflammation
High-sensitivity C-reactive protein (hs-CRP)
Major risk factors for chronic inflammation in vascular disease
Metabolic syndromes - insulin resistance - DM – pro-inflammatory state - HTN - Abd. Obesity
**Cigarette smoking **(vaping, marijuana ect.)
**Elevated LDL-C **(low-density lipoprotein-cholesterol: “bad” chol. )
Small LDL particles increase CAD risk
Penetrate endothelial barrier 2X more than large particles
Associated with high triglycerides, Low HDL, metabolic syndromes
**Low HDL ** (high-density lipoprotein: “good” chol. )
Absorbs and transports to the liver
High levels are best
Genetics
Aging
Pathophysiology of Atherosclerosis
Generalized inflammatory disorder
Endothelial dysfunction
Vaso-protective effects - Nitric Oxide
Formation of intimal plaques
Oxidative lipids -inflammatory cells -smooth muscle cells -connective tissue fibers -calcium deposits
Endothelial damage
Inflammation
Hypercoagulability
Low-density lipoproteins
Vasoactive influences
Medical Management of Atherosclerosis
Antihypertensives
beta-blockers - ACE inhibitors
Statin drugs
Antiplatelet
ASA - Plavix - glycoprotein Iib/IIIa inhibitors
Cessation of smoking
Normal Cerebral Vascular System and its disease state
Cerebral Blood Flow & Metabolism
* Primarily responsible for the Delivery of O2 and glucose
Cerebral circulation (CBF)
* Internal carotids arteries give 80% of flow to the head
* Vertebral arteries give 20% of flow to the head
* Collateral channels come off of these
Auto-regulated: CBF/CMRO2 coupling they match each other. They are in balance and go up and down together.
* To match cerebral metabolic rate of oxygen CMRO2
3 ml O2 to every 100Gm brain flow per min
* Coupled: increased and decreased together
* In which situations are they Uncoupled? (pathology/medications)
Carotid Disease
Bilateral in about 1/2 of all cases
Atherosclerotic plaque - Lateral aspect of the bifurcation and extends into the internal and external arteries
Primarily a problem of embolization
May manifest as asymptomatic bruit or Amaurosis fugax (monocular transient blindness)
TIA vs RIND (resolution 24 vs > 24hrs)
Carotid Disease
Bilateral in about 1/2 of all cases
Atherosclerotic plaque - Lateral aspect of the bifurcation and extends into the internal and external arteries
Primarily a problem of embolization
May manifest as asymptomatic bruit or Amaurosis fugax (monocular transient blindness)
TIA vs RIND (resolution 24 vs > 24hrs)
TIA =
Transient ischemic attack
Can last 2-15 minutes or up to 24 hours
RIND =
Reversible Ischemic Neurologic Deficit
Can last up to 7 days
Stroke in evolution AKA ___
Progressive Stroke
(stroke with neurological deficits that continue to worsen for hours or days after onset)
Completed stroke
Established neurological deficit that is irreversible or only partly reversible
Anesthetic Goals for Carotid Endartarectomy
- Prevention and prompt detection of cerebral and myocardial ischemia
- Maintenance of hemodynamic stability
- Rapid recovery from anesthetic drug effects for prompt evaluation of neurologic function
Clinical Focal Neurological Signs
- Presentation – contralateral
- Weakness and numbness
- Dysphasia, dyspraxia, and confusion (dominant hemisphere), transient
- Blurring of vision or blindness
(Ipsilateral eye), homonymous visual field loss; ipsilateral headache
Appropriate Candidates for Carotid Endartarectomy
- Symptomatic 70-99% stenosis
- TIAs or non-disabling stroke
- Surgically accessible stenosis
- Stable medical condition
Inappropriate Candidates for Carotid Endartarectomy
- Asymptomatic <60% stenosis
- Symptomatic or asymptomatic with
- Intracranial stenosis more severe than the extracranial stenosis
- Uncontrolled DM, HTN, CHF, Unstable Angina
- A major neurologic deficit or decreased LOC
Uncertain candidates for a CEA (carotid endartarectomy)
Symptomatic <70% stenosis
TIAs or nondisabling stroke
Surgically accessible stenosis
Stable medical and neurologic condition
Asymptomatic >60% stenosis
Surgically accessible stenosis
Stable medical condition
Pre-anesthetic assessment for CEA
- State of health
History, physical exam and chart review - Coexisting diseases
CAD, HTN, PVD, COPD, CRI, and DM - Adverse affects from hyperglycemia
- Cardiac complications
CHF and MI - Cerebral Angiogram
Contralateral carotid disease or poor collaterals - Risk stratification scheme
Formula for CBF
Cerebral Blood Flow
CPP/CVR (Cerebral Vascular Resistance)